Molecular detection of CF lung pathogens: current status and future potential (Q38080967)

28 August 2017

Molecular detection of CF lung pathogens: current status and future potential (English)

1 reference

28 August 2017

2

1 reference

28 August 2017

4

1 reference

28 August 2017

Michael M Tunney

5

0 references

author name string

Sally H Pattison

series ordinal

1

1 reference

PubMed ID

23402821

28 August 2017

Martin Crockard

series ordinal

3

1 reference

28 August 2017

10 February 2013

1 reference

Journal of Cystic Fibrosis

28 August 2017

1 reference

28 August 2017

12

1 reference

28 August 2017

3

1 reference

28 August 2017

194-205

1 reference

Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience

28 August 2017

1 reference

12 December 2020

Cost-effective airway cultures in the cystic fibrosis patient

1 reference

12 December 2020

Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients

1 reference

12 December 2020

Cost-effectiveness of switch to matrix-assisted laser desorption ionization-time of flight mass spectrometry for routine bacterial identification.

1 reference

12 December 2020

Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.

1 reference

12 December 2020

Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients

1 reference

12 December 2020

A real-time PCR antibiogram for drug-resistant sepsis

1 reference

12 December 2020

Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States

1 reference

12 December 2020

Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

1 reference

12 December 2020

Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis

1 reference

12 December 2020

Nucleic acid sequence-based amplification

1 reference

12 December 2020

Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures

1 reference

12 December 2020

Matrix-assisted laser desorption ionisation-time-of of-flight mass spectrometry of intact cells allows rapid identification of Burkholderia cepacia complex

1 reference

12 December 2020

Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis

1 reference

12 December 2020

Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with multiresistant strains of Pseudomonas aeruginosa

1 reference

12 December 2020

Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis.

1 reference

12 December 2020

Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis

1 reference

12 December 2020

Real-time PCR for universal antibiotic susceptibility testing.

1 reference

12 December 2020

A rapid antimicrobial susceptibility test for Bacillus anthracis

1 reference

12 December 2020

Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis

1 reference

12 December 2020

The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations

1 reference

12 December 2020

Culture enriched molecular profiling of the cystic fibrosis airway microbiome

1 reference

12 December 2020

Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi

1 reference

12 December 2020

Intraspecies signaling involving the diffusible signal factor BDSF (cis-2-dodecenoic acid) influences virulence in Burkholderia cenocepacia.

1 reference

12 December 2020

Cystic fibrosis: a review of pulmonary infections and interventions

1 reference

12 December 2020

Pseudomonas aeruginosa: all roads lead to resistance

1 reference

12 December 2020

A retrospective analysis of biofilm antibiotic susceptibility testing: A better predictor of clinical response in cystic fibrosis exacerbations

1 reference

12 December 2020

Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.

1 reference

12 December 2020

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

1 reference

12 December 2020

Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis

1 reference

12 December 2020

16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory.

1 reference

12 December 2020

EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates

1 reference

12 December 2020

Clinical significance of microbial infection and adaptation in cystic fibrosis

1 reference

12 December 2020

Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.

1 reference

12 December 2020

Antimicrobial susceptibility and synergy studies of cystic fibrosis sputum by direct sputum sensitivity testing

1 reference

12 December 2020

Decade-long bacterial community dynamics in cystic fibrosis airways

1 reference

12 December 2020

Rapid identification of Burkholderia cepacia complex species including strains of the novel Taxon K, recovered from cystic fibrosis patients by intact cell MALDI-ToF mass spectrometry

1 reference

12 December 2020

The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management

1 reference

12 December 2020

Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis

1 reference

12 December 2020

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

1 reference

12 December 2020

Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities

1 reference

12 December 2020

Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols.

1 reference

12 December 2020

A guide for diagnostic evaluations

1 reference

12 December 2020

One-day workflow scheme for bacterial pathogen detection and antimicrobial resistance testing from blood cultures

1 reference

12 December 2020

Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection.

1 reference

12 December 2020

Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing.

1 reference

12 December 2020

PCR and the detection of Pseudomonas aeruginosa in respiratory samples of CF patients. A literature review

1 reference

12 December 2020

Pseudomonas aeruginosa - a phenomenon of bacterial resistance

1 reference

12 December 2020

Antibiotic susceptibility testing of grown blood cultures by combining culture and real-time polymerase chain reaction is rapid and effective.

1 reference

12 December 2020

Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009.

1 reference

12 December 2020

Bacterial cis-2-unsaturated fatty acids found in the cystic fibrosis airway modulate virulence and persistence of Pseudomonas aeruginosa

1 reference

12 December 2020

Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis.

1 reference

12 December 2020

Prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability

1 reference

12 December 2020

Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients

1 reference

12 December 2020

Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa.

1 reference

12 December 2020

Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients

1 reference

12 December 2020

Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations

1 reference

12 December 2020

Performance comparison of benchtop high-throughput sequencing platforms

1 reference

12 December 2020

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis.

1 reference

12 December 2020

Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection

1 reference

12 December 2020

Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

1 reference

12 December 2020

A window into third-generation sequencing

1 reference

12 December 2020

Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial.

1 reference

12 December 2020

Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.

1 reference

12 December 2020

Superiority of molecular techniques for identification of gram-negative, oxidase-positive rods, including morphologically nontypical Pseudomonas aeruginosa, from patients with cystic fibrosis

1 reference

12 December 2020

Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections

1 reference

12 December 2020

Use of matrix assisted laser desorption ionisation-time of flight mass spectrometry in a paediatric clinical laboratory for identification of bacteria commonly isolated from cystic fibrosis patients

1 reference

12 December 2020

Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients

1 reference

12 December 2020

Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.

1 reference

12 December 2020

Detection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis

1 reference

12 December 2020

Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling.

1 reference

12 December 2020

Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases

1 reference

12 December 2020

Standards of care for patients with cystic fibrosis: a European consensus

1 reference

12 December 2020

Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients

1 reference

12 December 2020

Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis

1 reference

12 December 2020

10.1016/J.JCF.2013.01.007

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23402821